Relvar Ellipta 184/22 (Fluticasone furoate + vilanterol Inhaler) 184mcg/22mcg x 30doses

Relvar Ellipta 184/22 is an inhaled corticosteroid and long-acting beta agonist combination used for asthma and COPD maintenance. This inhaler delivers 184mcg fluticasone furoate and 22mcg vilanterol per dose in a convenient 30-dose foil strip. Suitable for adults and adolescents 12 years and older.

Strength

184mcg/22mcg x 30doses

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Glaxosmithkline

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Relvar Ellipta 184/22 is prescribed for daily maintenance treatment of asthma in patients not adequately controlled on inhaled corticosteroids alone. It is also used to reduce exacerbations and improve lung function in adults with chronic obstructive pulmonary disease (COPD). This combination inhaler helps control symptoms such as wheezing, shortness of breath, and chest tightness. It is not intended for acute symptom relief or sudden breathing problems.

Side Effects

Users may notice improved breathing and reduced frequency of asthma or COPD flare-ups within days to weeks of regular use. Some individuals report easier daily activities due to better lung function. The inhaler’s design helps deliver medication directly to the lungs for targeted action. Consistent use supports long-term control of respiratory symptoms.

Precautions & Warnings

Store the inhaler at room temperature away from moisture and direct heat. Keep the inhaler in its foil tray until ready to use to protect from humidity. Always check the dose counter before and after use to ensure the correct number of doses remain. Rinse your mouth with water after each use to reduce the risk of oral thrush.

Avoid Interactions

Avoid using Relvar Ellipta 184/22 with other long-acting beta agonists or high-dose inhaled corticosteroids unless directed by a healthcare provider. Certain medications, such as strong CYP3A4 inhibitors like ketoconazole, may increase the risk of side effects by raising drug levels in the body. Discuss all current medications, including over-the-counter and herbal products, with your healthcare provider before starting this inhaler.

Frequently Asked Questions

It is used for daily maintenance treatment of asthma and to reduce flare-ups in adults with COPD.

Open the foil tray, slide the cover down to activate the dose, and inhale the medication as directed by your healthcare provider.

Do not stop or reduce your dose without consulting your healthcare provider, as sudden discontinuation may worsen your condition.

Take the missed dose as soon as you remember, unless it is almost time for your next scheduled dose. Skip the missed dose if it is close to the next one.

Common side effects may include headache, throat irritation, or oral thrush. Rinse your mouth after use to minimize these effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.